Revolutionizing Wound Care: Arch Therapeutics Launches Groundbreaking Multi-Site Clinical Study for AC5 Advanced Wound System
Arch Therapeutics Launches Multi-Site Clinical Study for AC5® Advanced Wound System Expected to Accelerate Sales Opportunities in Doctor’s Office and Wound Clinics FRAMINGHAM, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today announced that it…